Jenkins John Kenneth 4
4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Jun 6, 2018
Insider Transaction Report
Form 4
Jenkins John Kenneth
Director
Transactions
- Award
Stock Option(right to buy)
2018-06-05+68,000→ 68,000 totalExercise: $6.00Exp: 2028-06-05→ Common Stock (68,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.